专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP2414844B1 FIBROSIS BIOMARKER ASSAY 有权
标题翻译：生物标志物囊性纤维化
公开(公告)号：EP2414844B1
公开(公告)日：2014-12-10
申请号：EP10715752.1
申请日：2010-03-29
申请人： Nordic Bioscience A/S , Novartis AG
发明人： VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJOT-ARKIL, Helene , SEGOVIA-SILVESTRE, Antonio , VASSILIADIS, Efstathios
IPC分类号： G01N33/68
CPC分类号： G01N33/6893 , C12Q1/37 , G01N2333/4737 , G01N2333/78 , G01N2800/085 , G01N2800/32 , G01N2800/50
摘要： Methods of diagnosis or of quantitation of fibrosis comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of fibrosis. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope, and wherein said protein is collagen type III, collagen type I, collagen type IV, collagen type V, or collagen type VI, elastin, biglycan, decorin, lumican, versican, perlecan, neurocan, brevican, fibromodulin, serglycin, syndecan, betaglycan, vimentin, or C-reactive protein.

2. 发明公开

EP2414844A2 FIBROSIS BIOMARKER ASSAY 有权
标题翻译：生物标志物囊性纤维化
公开(公告)号：EP2414844A2
公开(公告)日：2012-02-08
申请号：EP10715752.1
申请日：2010-03-29
申请人： Nordic Bioscience A/S , Novartis AG
发明人： VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJOT-ARKIL, Helene , SEGOVIA-SILVESTRE, Antonio , VASSILIADIS, Efstathios
IPC分类号： G01N33/68
CPC分类号： G01N33/6893 , C12Q1/37 , G01N2333/4737 , G01N2333/78 , G01N2800/085 , G01N2800/32 , G01N2800/50
摘要： Methods of diagnosis or of quantitation of fibrosis comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of fibrosis. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope, and wherein said protein is collagen type III, collagen type I, collagen type IV, collagen type V, or collagen type VI, elastin, biglycan, decorin, lumican, versican, perlecan, neurocan, brevican, fibromodulin, serglycin, syndecan, betaglycan, vimentin, or C-reactive protein.

3. 发明申请

WO2013011056A2 PATHOLOGY BIOMARKER ASSAY 审中-公开
标题翻译：病理生物标志物测定
公开(公告)号：WO2013011056A2
公开(公告)日：2013-01-24
申请号：PCT/EP2012/064090
申请日：2012-07-18
申请人： NORDIC BIOSCIENCE A/S , VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJØT-ARKIL, Helene , VASSILIADIS, Efstathios
发明人： VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJØT-ARKIL, Helene , VASSILIADIS, Efstathios
IPC分类号： C07K14/78 , G01N33/53 , G01N33/68 , C07K7/00
CPC分类号： G01N33/6893 , C07K14/78 , C12Q1/37 , G01N2333/4737 , G01N2333/775 , G01N2333/78 , G01N2800/32
摘要： Methods of diagnosis or of quantitation of pathological conditions comprise conducting an immunoassay to measure neoepitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent o pathology. The immunoassay is conducted by a method comprising contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neoepitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope. Neo-epitopes from, collagen type I, collagen type III, collagen type IV, collagen type V, collagen type VI, elastin, biglycan, decorin, lumican, versican, C-reactive protein, ApoE and laminins are described.
摘要翻译：诊断或定量病理状况的方法包括进行免疫测定以测量天然存在于bioflui样品中的含neoepitope的蛋白质片段，并且将所述患者中所述测量值在正常水平以上的升高与存在或病理程度。所述免疫测定法通过包括使天然存在于所述样品中的蛋白质片段与通过蛋白酶裂解蛋白质形成的新表位反应的免疫结合配偶体接触并测量肽片段与所述免疫结合配偶体的结合程度来测量其中包含所述新表位的蛋白质片段。描述了来自I型胶原蛋白，III型胶原蛋白，IV型胶原蛋白，V型胶原蛋白，VI型胶原蛋白，弹性蛋白，双糖链蛋白聚糖，核心蛋白聚糖，lumican，多功能蛋白聚糖，C反应蛋白，ApoE和层粘连蛋白的新表位。

4. 发明申请

WO2010115749A2 FIBROSIS BIOMARKER ASSAY 审中-公开
标题翻译： FIBROSIS BIOMARKER测定
公开(公告)号：WO2010115749A2
公开(公告)日：2010-10-14
申请号：PCT/EP2010/054096
申请日：2010-03-29
申请人： NORDIC BIOSCIENCE A/S , VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJOT-ARKIL, Helene , SEGOVIA-SILVESTRE, Antonio , VASSILIADIS, Efstathios
发明人： VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJOT-ARKIL, Helene , SEGOVIA-SILVESTRE, Antonio , VASSILIADIS, Efstathios
IPC分类号： G01N33/68
CPC分类号： G01N33/6893 , C12Q1/37 , G01N2333/4737 , G01N2333/78 , G01N2800/085 , G01N2800/32 , G01N2800/50
摘要： Methods of diagnosis or of quantitation of fibrosis comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of fibrosis. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope, and wherein said protein is collagen type III, collagen type I, collagen type IV, collagen type V, or collagen type VI, elastin, biglycan, decorin, lumican, versican, perlecan, neurocan, brevican, fibromodulin, serglycin, syndecan, betaglycan, vimentin, or C-reactive protein.
摘要翻译：诊断或定量纤维化的方法包括进行免疫测定以测量天然存在于生物流体样品中的含有蛋白质片段的蛋白质片段，并将所述患者中所述患者的高度高于正常水平与所述纤维化的存在或程度相关联。免疫测定通过以下方法进行，该方法包括：使天然存在于所述样品中的蛋白片段与免疫结合配偶体接触，所述免疫结合配偶体与通过蛋白酶切割蛋白质形成的新表位反应，并测量肽片段与所述免疫结合的结合程度其中所述蛋白质是III型胶原，I型胶原，IV型胶原，V型胶原或VI型胶原蛋白，弹性蛋白，双糖链蛋白聚糖，核心蛋白聚糖，多巴胺，多聚核苷酸，神经鞘蛋白，短纤维蛋白原，纤维调节蛋白，血清蛋白，syndecan，betaglycan，波形蛋白或C反应蛋白。

5. 发明公开

EP3239173A2 PATHOLOGY BIOMARKER ASSAY 审中-公开
公开(公告)号：EP3239173A2
公开(公告)日：2017-11-01
申请号：EP17172678.9
申请日：2012-07-18
申请人： Nordic Bioscience A/S
发明人： VEIDAL, Sanne , KARSDAL, Morten Asser , LEEMING, Diana J. , BARASCUK, Natasha , SKJOT-ARKIL, Helene , VASSILIADIS, Efstathios
IPC分类号： C07K14/78 , G01N33/53 , G01N33/68 , C07K7/00
CPC分类号： G01N33/6893 , C07K14/78 , C12Q1/37 , G01N2333/4737 , G01N2333/775 , G01N2333/78 , G01N2800/32
摘要： Methods of diagnosis or of quantitation of pathological conditions comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of pathology. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope. Neo-epitopes from, collagen type I, collagen type III, collagen type IV, collagen type V, collagen type VI, elastin, biglycan, decorin, lumican, versican, C-reactive protein, ApoE and laminins are described.

6. 发明公开

EP3239173A3 PATHOLOGY BIOMARKER ASSAY 审中-公开
标题翻译：病理生物标志物测定
公开(公告)号：EP3239173A3
公开(公告)日：2018-01-24
申请号：EP17172678.9
申请日：2012-07-18
申请人： Nordic Bioscience A/S
发明人： VEIDAL, Sanne, Skovgård , KARSDAL, Morten Asser , LEEMING, Diana J. , BARASCUK, Natasha , SKJOT-ARKIL, Helene , VASSILIADIS, Efstathios
IPC分类号： C07K14/78 , G01N33/53 , G01N33/68 , C07K7/00
CPC分类号： G01N33/6893 , C07K14/78 , C12Q1/37 , G01N2333/4737 , G01N2333/775 , G01N2333/78 , G01N2800/32
摘要： Methods of diagnosis or of quantitation of pathological conditions comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of pathology. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope. Neo-epitopes from, collagen type I, collagen type III, collagen type IV, collagen type V, collagen type VI, elastin, biglycan, decorin, lumican, versican, C-reactive protein, ApoE and laminins are described.
摘要翻译：诊断或定量病理状况的方法包括进行免疫测定以测量天然存在于bioflui样品中的含有新表位的蛋白质片段，并且将所述患者中的所述测量值在正常水平以上的升高与病理的存在或程度相关联。所述免疫测定法通过包括以下步骤的方法进行：使天然存在于所述样品中的蛋白质片段与免疫学结合配偶体接触，所述免疫学结合配偶体与通过蛋白酶裂解蛋白质形成的新表位反应并测量肽片段与所述免疫学结合的结合程度在其中测量包含所述新表位的蛋白质片段。描述了来自I型胶原蛋白，III型胶原蛋白，IV型胶原蛋白，V型胶原蛋白，VI型胶原蛋白，弹性蛋白，双糖链蛋白聚糖，核心蛋白聚糖，lumican，多功能蛋白聚糖，C-反应蛋白，ApoE和层粘连蛋白的新表位。

7. 发明授权

EP2734542B1 PATHOLOGY BIOMARKER ASSAY 审中-公开
公开(公告)号：EP2734542B1
公开(公告)日：2018-12-26
申请号：EP12740115.6
申请日：2012-07-18
申请人： Nordic Bioscience A/S
发明人： VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJØT-ARKIL, Helene , VASSILIADIS, Efstathios
IPC分类号： C07K14/78 , G01N33/53 , G01N33/68 , C07K7/00
CPC分类号： G01N33/6893 , C07K14/78 , C12Q1/37 , G01N2333/4737 , G01N2333/775 , G01N2333/78 , G01N2800/32
摘要： Methods of diagnosis or of quantitation of pathological conditions comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of pathology. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope. Neo-epitopes from, collagen type I, collagen type III, collagen type IV, collagen type V, collagen type VI, elastin, biglycan, decorin, lumican, versican, C-reactive protein, ApoE and laminins are described.

8. 发明公开

EP2734542A2 PATHOLOGY BIOMARKER ASSAY 审中-公开
标题翻译：生物标志物进行病理
公开(公告)号：EP2734542A2
公开(公告)日：2014-05-28
申请号：EP12740115.6
申请日：2012-07-18
申请人： Nordic Bioscience A/S
发明人： VEIDAL, Sanne S. , KARSDAL, Morten A. , LEEMING, Diana J. , BARASCUK, Natasha , SKJØT-ARKIL, Helene , VASSILIADIS, Efstathios
IPC分类号： C07K14/78 , G01N33/53 , G01N33/68 , C07K7/00
CPC分类号： G01N33/6893 , C07K14/78 , C12Q1/37 , G01N2333/4737 , G01N2333/775 , G01N2333/78 , G01N2800/32
摘要： Methods of diagnosis or of quantitation of pathological conditions comprise conducting an immunoassay to measure neo-epitope containing protein fragments naturally present in a bioflui sample, and associating an elevation of said measure in said patient above a normal level with the presence or extent of pathology. The immunoassay is conducted by a method comprising: contacting protein fragments naturally present in said sample with an immunological binding partner reactive with a neo-epitope formed by cleavage of a protein by a proteinase and measuring the extent of binding of peptide fragments to said immunological binding partner to measure therein protein fragments comprising said neo-epitope. Neo-epitopes from, collagen type I, collagen type III, collagen type IV, collagen type V, collagen type VI, elastin, biglycan, decorin, lumican, versican, C-reactive protein, ApoE and laminins are described.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式